Patents by Inventor Georges Daste

Georges Daste has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chewable composition for oral administration and process for preparing thereof
    Patent number: 9474713
    Abstract: The present invention relates to chewable compositions for oral administration, said compositions comprising high(methyl)pectin, glycerol and water. Advantageously, the chewable composition can comprise a drug substance. The present invention also concerns a process for preparing the chewable composition and the use of said chewable composition as a medicament.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: October 25, 2016
    Assignee: SANOFI
    Inventors: Georges Daste, Benjamin Derouet, Marie Renouard
  • CHEWABLE COMPOSITION FOR ORAL ADMINISTRATION AND PROCESS FOR PREPARING THEREOF
    Publication number: 20150374622
    Abstract: The present invention relates to chewable compositions for oral administration, said compositions comprising high(methyl)pectin, glycerol and water. Advantageously, the chewable composition can comprise a drug substance. The present invention also concerns a process for preparing the chewable composition and the use of said chewable composition as a medicament.
    Type: Application
    Filed: February 12, 2014
    Publication date: December 31, 2015
    Applicant: SANOFI
    Inventors: Georges DASTE, Benjamin DEROUET, Marie RENOUARD
  • Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an HMG-CoA-reductase inhibitor
    Patent number: 6218403
    Abstract: The present invention relates to a pharmaceutical composition containing: (a) a thienopyridine derivative of formula  in which R is hydrogen or a (C1-C4)alkoxycarbonyl group, or one of its pharmaceutically acceptable salts; and (b) an HMG-CoA reductase inhibitor.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: April 17, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: Georges Daste, Jean Marc Herbert
  • Pharmaceutical composition providing the sustained-release of valproic acid
    Patent number: 5019398
    Abstract: The object of the invention is a tablet sustaining release for more than 8 hours, the active ingredient of which is constituted by the complex formed between one mole of valproic acid and one mole of sodium valproate.
    Type: Grant
    Filed: February 23, 1990
    Date of Patent: May 28, 1991
    Assignee: Sanofi
    Inventor: Georges Daste